Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.17 (
lysozyme
)
21,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Destabilase-
lysozyme
(mlDL) is an enzyme secreted by the salivary gland cells of medicinal
leeches
. Destabilase-
lysozyme
possesses
lysozyme
and isopeptidase activities. We generated recombinant destabilase-
lysozyme
isoform 2 in three expression systems, i.e., in the bacteria Escherichia coli, in the yeast Pichia pastoris, and in the human cell line Expi293F. In E. coli, we generated both polypeptide in inclusion bodies that was later undergone to the refolding and soluble protein that had been fused with the chaperone SlyD. The chaperone was later cleaved by a specific TEV-protease. In cultures of the yeast P. pastoris and the human cell line Expi293F, the soluble form of destabilase-
lysozyme
was accumulated in the culture media. For the generated enzymes, we determined the
lysozyme
, isopeptidase and fibrinolytic activities and tested their general antimicrobial effects. The comparisons of the enzymes generated in the different expression systems revealed that all of the destabilase-lysozymes obtained in the soluble forms possessed equal levels of
lysozyme
, isopeptidase and fibrinolytic activities that exceeded several to ten times the levels of the same activities of the destabilase-
lysozyme
renaturated from the inclusion bodies. A similar pattern of the differences in the levels of the general antimicrobial effects was observed for the destabilase-lysozymes generated in the soluble form and as inclusion bodies.
...
PMID:Generation of recombinant destabilase-lysozyme from medicinal leeches in three different expression systems. 2627 52